No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
STAA240517P42500
- 3.20
- +2.47+338.36%
15min DelayTrading May 8 12:15 ET
3.20High1.45Low
1.55Open0.73Pre Close33 Volume235 Open Interest42.50Strike Price5.74KTurnover46.56%IV-0.90%PremiumMay 17, 2024Expiry Date2.49Intrinsic Value100Multiplier9DDays to Expiry0.71Time Value100Contract SizeAmericanOptions Type-0.6910Delta0.1164Gamma14.04Leverage Ratio-0.0541Theta-0.0067Rho-9.70Eff Leverage0.0231Vega
Intraday
- 5D
- 1D
News
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Price Target Cut to $43.00/Share From $46.00 by Canaccord Genuity
Staar Surgical Price Target Cut to $43.00/Share From $46.00 by Canaccord Genuity
STAAR Surgical Shares Are Trading Lower After the Company Reported Q1 Financial Results.
STAAR Surgical Shares Are Trading Lower After the Company Reported Q1 Financial Results.
Canadian Investment Banking Group: Maintaining the Staar Surgical (STAA.US) rating, adjusted from holding to holding rating, and adjusted the target price from $46.00 to $43.00.
Canadian Investment Banking Group: Maintaining the Staar Surgical (STAA.US) rating, adjusted from holding to holding rating, and adjusted the target price from $46.00 to $43.00.
Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $43
Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 to $43.
Staar Surgical Price Target Raised to $40.00/Share From $33.00 by Piper Sandler
Staar Surgical Price Target Raised to $40.00/Share From $33.00 by Piper Sandler